Valuation Clinuvel Pharmaceuticals Limited

Stocks

Market Closed - Australian S.E. 02:10:10 2026-09-25 EDT			5-day change	1st Jan Change
8.020 ^AUD	-2.91%		-4.18%	-35.63%

09-09	Clinuvel Pharmaceuticals Ltd Completes Development Of Zerokin Single-Use Administration Device For Controlled-Release Formulations	CI
09-07	Clinuvel Pharmaceuticals Completes Development of Proprietary Drug Delivery Device	MT

Data adjusted to current consolidation scope

Fiscal Period: June	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	733.7	883.5	769.8	520.3	518.4	404.4	-	-
Change	-	20.4%	-12.87%	-32.41%	-0.36%	-21.98%	-	-
Enterprise Value (EV) ¹	612.2	726.6	585.9	296.2	309.1	121.3	88.56	49.7
Change	-	18.69%	-19.37%	-49.45%	4.37%	-60.77%	-26.97%	-43.88%
P/E	36.8x	30.3x	22x	14.5x	15.4x	11.6x	11.1x	7.46x
PBR	5.84x	5.37x	3.79x	2.17x	1.91x	1.33x	1.19x	1.03x
PEG	-	0.6x	1.2x	5.06x	-2.21x	3.05x	2.6x	0.2x
Capitalization / Revenue	11.2x	11.3x	8.73x	5.48x	5.51x	4.26x	4x	2.92x
EV / Revenue	9.32x	9.28x	6.64x	3.12x	3.29x	1.28x	0.87x	0.36x
EV / EBITDA	16.4x	19.5x	12x	6.84x	8.09x	3.2x	2.23x	0.81x
EV / EBIT	16.7x	20x	12.3x	7.03x	8.31x	3.29x	2.3x	0.83x
EV / FCF	15.5x	20.2x	18.6x	7.26x	8.76x	3.31x	2.19x	0.86x
FCF Yield	6.44%	4.94%	5.37%	13.8%	11.4%	30.2%	45.7%	117%
Dividend per Share ²	0.04	0.05	0.05	0.05	0.05	0.0547	0.0608	0.0882
Rate of return	0.27%	0.28%	0.33%	0.48%	0.49%	0.68%	0.76%	1.1%
EPS ²	0.403	0.591	0.698	0.718	0.668	0.6934	0.723	1.075
Distribution rate	9.93%	8.46%	7.16%	6.96%	7.49%	7.88%	8.41%	8.2%
Net sales ¹	65.72	78.32	88.18	95.02	94.02	94.86	101.2	138.5
EBITDA ¹	37.44	37.2	48.95	43.3	38.2	37.94	39.71	61.2
EBIT ¹	36.68	36.41	47.81	42.12	37.21	36.85	38.54	59.72
Net income ¹	20.88	30.6	35.64	36.17	33.92	35.1	36.66	54.44
Net Debt ¹	-121.5	-156.8	-183.9	-224.1	-209.3	-283.2	-315.9	-354.7
Reference price ²	14.850	17.880	15.370	10.380	10.280	8.020	8.020	8.020
Nbr of stocks (in thousands)	49,410	49,410	50,083	50,124	50,428	50,428	-	-
Announcement Date	8/30/22	8/29/23	8/28/24	8/27/25	8/27/26	-	-	-

¹AUD in Million²AUD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CLINUVEL PHARMACEUTICALS LIMITED	11.57x	1.28x	3.2x	0.68%	284M
REGENERON PHARMACEUTICALS, INC.	17.96x	4.21x	9.93x	0.5%	78.69B
MODERNA, INC.	-23.72x	36.06x	-23.41x	-.--%	79.4B
CSL LIMITED	20.46x	4.36x	13.5x	2.42%	59.52B
SAMSUNG BIOLOGICS CO.,LTD.	33.28x	11.32x	21.7x	-.--%	46.53B
UCB	21.44x	4.75x	13.52x	0.68%	46.58B
BIOGEN INC.	37.12x	3.69x	13.85x	-.--%	33.63B
INCYTE CORPORATION	55.29x	3.51x	27.23x	-.--%	25.11B
INNOVENT BIOLOGICS, INC.	63.28x	7.06x	42.21x	-.--%	22.13B
SWEDISH ORPHAN BIOVITRUM AB	22.86x	4.91x	12.8x	-.--%	15.31B
Average	25.95x	8.12x	13.45x	0.43%	40.72B
Weighted average by Cap.	18.87x	11.41x	8.95x	0.53%